Enovis to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Enovis (NYSE: ENOV) has announced its management team's participation in two upcoming investor conferences. At the Jefferies London Healthcare Conference, Chair and CEO Matt Trerotola and CFO Ben Berry will join a fireside chat on November 20th at 12:00 p.m. GMT. Subsequently, CFO Ben Berry will participate in the Evercore 7th Annual HealthCONx Conference on December 4th at 10:50 a.m. ET.

Both events will be available via live audio webcasts and replays on the company's website under the Investors tab. Enovis is a medical technology growth company focused on developing clinically differentiated solutions for better patient outcomes and workflow transformation in orthopedics and beyond.

News Market Reaction – ENOV

-0.59%

-0.59% Session move

In the trading session that priced this news, ENOV declined 0.59%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Wilmington, DE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:

• Jefferies London Healthcare Conference: Matt Trerotola, Chair and Chief Executive Officer, and Ben Berry, Chief Financial Officer, will participate in a fireside chat on Wednesday, November 20th at 12:00 p.m. GMT (7:00 a.m. ET)
• Evercore 7th Annual HealthCONx Conference: Ben Berry, Chief Financial Officer, will participate in a fireside chat on Wednesday, December 4th at 10:50 a.m. ET.
  

A link to the live audio webcasts, as well as a replay of these events, will be available on the Company’s website under the Investors tab at Events and Presentations.

ABOUT ENOVIS

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV.  For more information about Enovis, please visit www.enovis.com.

Contact:

Kyle Rose
Vice President, Investor Relations
Enovis Corporation
investorrelations@enovis.com

FAQ

When is Enovis (ENOV) presenting at the Jefferies London Healthcare Conference?

Enovis will present at the Jefferies London Healthcare Conference on November 20th at 12:00 p.m. GMT (7:00 a.m. ET).

Who will represent Enovis (ENOV) at the Evercore HealthCONx Conference?

Ben Berry, Chief Financial Officer of Enovis, will participate in a fireside chat at the Evercore HealthCONx Conference.

Where can investors watch Enovis (ENOV) conference presentations?

Investors can access live audio webcasts and replays of the presentations on Enovis's website under the Investors tab at Events and Presentations.

What upcoming investor conferences will Enovis (ENOV) attend in 2024?

Enovis will attend the Jefferies London Healthcare Conference on November 20th and the Evercore 7th Annual HealthCONx Conference on December 4th, 2024.